We are improving our search experience. To check which content you have full access to, or for advanced search, go back to the old search.

Search

Please fill in this field.

Search Results

Showing 101-120 of 7,359 results
  1. CD90 is regulated by notch1 and hallmarks a more aggressive intrahepatic cholangiocarcinoma phenotype

    Background

    Intrahepatic Cholangiocarcinoma (iCCA) is characterized by a strong stromal reaction playing a role in tumor progression. Thymus cell...

    Serena Mancarella, Grazia Serino, ... Gianluigi Giannelli in Journal of Experimental & Clinical Cancer Research
    Article Open access 16 February 2022
  2. Neurodegenerative Disorders

    This chapter deals with the most common neurodegenerative diseases: Alzheimer’s disease, Parkinson’s disease, Huntington’s disease (HD), amyotrophic...
    Wolfgang Walz in The Gliocentric Brain
    Chapter 2023
  3. Introduction to Alzheimer’s Disease

    Alzheimer’s disease (AD) is a progressive neurodegenerative ailment associated with intracellular amyloid aggregates and extracellular...
    Thamilarasan Manivasagam, Ravi Surya, ... Yoga Rajamani in Nutraceuticals for Alzheimer's Disease: A Promising Therapeutic Approach
    Chapter 2023
  4. Dynamic Docking Using Multicanonical Molecular Dynamics: Simulating Complex Formation at the Atomistic Level

    Multicanonical molecular dynamics (McMD)-based dynamic docking has been applied to predict the native binding configurations for several protein...
    Gert-Jan Bekker, Narutoshi Kamiya in Protein-Ligand Interactions and Drug Design
    Protocol 2021
  5. Notch activation suppresses endothelial cell migration and sprouting via miR-223-3p targeting Fbxw7

    Angiogenesis involves temporo-spatially coordinated endothelial cell (EC) proliferation, differentiation, migration, and sprouting. Notch signaling...

    Ruonan Wang, Ziyan Yang, ... Hua Han in In Vitro Cellular & Developmental Biology - Animal
    Article 22 February 2022
  6. Pathophysiology and Management Approaches in Alzheimer’s Disease

    Alzheimer’s disease is recognized as a progressive multifarious neurodegenerative disorder that is pathologically characterized by the deposition of...
    Chapter 2023
  7. Identification of potential marine bioactive compounds from brown seaweeds towards BACE1 inhibitors: molecular docking and molecular dynamics simulations approach

    The drug target protein β-secretase 1 (BACE1) is one of the promising targets in the design of the drugs to control Alzheimer’s disease (AD)....

    Anantha Krishnan Dhanabalan, Saranya Vasudevan, ... Mohd Shahnawaz Khan in In Silico Pharmacology
    Article 06 May 2024
  8. Dysfunctional γ-Secretase in Familial Alzheimer’s Disease

    Genetics strongly implicate the amyloid β-peptide (Aβ) in the pathogenesis of Alzheimer’s disease. Dominant missense mutation in the presenilins and...

    Michael S. Wolfe in Neurochemical Research
    Article 04 April 2018
  9. Design of Therapeutic Nanomaterials for Amelioration of Alzheimer’s Disease

    Alzheimer’s disease is the most common form of progressive late-onset dementia. The prevalence of multidimensional adversity of Alzheimer’s disease...
    Chapter 2023
  10. Aluminum-Induced AD-Like Pathological Features

    Alzheimer’s disease (AD) is the most prevalent neurodegenerative disease characterized by neural aberrations in regions associated with higher...
    Chapter 2023
  11. NOTCH1-Induced T-Cell Acute Lymphoblastic Leukemia In Vivo Models

    T-cell acute lymphoblastic leukemia (T-ALL) is primarily a NOTCH1-driven disease, which represents approximately 15% of pediatric and 25% of adult...
    Anna Campagnari, Laura Belver in Mouse Models of Cancer
    Protocol 2024
  12. Elucidating the Molecular Mechanisms Involved in Regulating Alzheimer’s Disease by Capsaicin

    More than 40 million people worldwide are presently afflicted by Alzheimer’s disease (AD), a neurodegenerative condition that is expected to spread...
    Akila Muthuramalingam, Mohd Kashif, ... Ashok Kumar Pandurangan in Capsaicinoids
    Chapter 2024
  13. Presenilin 1 phosphorylation regulates amyloid-β degradation by microglia

    Amyloid-β peptide (Aβ) accumulation in the brain is a hallmark of Alzheimer’s Disease. An important mechanism of Aβ clearance in the brain is uptake...

    Jose Henrique Ledo, Thomas Liebmann, ... Paul Greengard in Molecular Psychiatry
    Article Open access 13 August 2020
  14. Regulation of Ryanodine Receptor-Dependent Neurotransmitter Release by AIP, Calstabins, and Presenilins

    Ryanodine receptors (RyRs) are Ca2+ release channels located in the endoplasmic reticulum membrane. Presynaptic RyRs play important roles in...
    Zhao-Wen Wang, Longgang Niu, Sadaf Riaz in Molecular Mechanisms of Neurotransmitter Release
    Chapter 2023
  15. Dual-Specificity Phosphatase 15 (DUSP15) Modulates Notch Signaling by Enhancing the Stability of Notch Protein

    Dual-specificity phosphatases (DUSPs) comprise a unique group of enzymes that dephosphorylate signaling proteins at both phospho-serine/threonine and...

    Noopur Bhore, Bo-Jeng Wang, ... Yung-Feng Liao in Molecular Neurobiology
    Article 08 January 2021
  16. Rotenone Induces a Neuropathological Phenotype in Cholinergic-like Neurons Resembling Parkinson’s Disease Dementia (PDD)

    Parkinson’s disease with dementia (PDD) is a neurological disorder that clinically and neuropathologically overlaps with Parkinson’s disease (PD) and...

    Daniela Giraldo-Berrio, Miguel Mendivil-Perez, ... Marlene Jimenez-Del-Rio in Neurotoxicity Research
    Article Open access 06 June 2024
  17. Loss of Numb promotes hepatic progenitor expansion and intrahepatic cholangiocarcinoma by enhancing Notch signaling

    Numb, a stem cell fate determinant, acts as a tumor suppressor and is closely related to a wide variety of malignancies. Intrahepatic...

    Yuke Shu, Qing Xu, ... Hong Bu in Cell Death & Disease
    Article Open access 19 October 2021
  18. The aldehyde dehydrogenase 2 rs671 variant enhances amyloid β pathology

    In the ALDH2 rs671 variant, a guanine changes to an adenine, resulting in a dramatic decrease in the catalytic activity of the enzyme....

    **a Wang, Jiayu Wang, ... Wei Ge in Nature Communications
    Article Open access 22 March 2024
  19. Aβ profiles generated by Alzheimer’s disease causing PSEN1 variants determine the pathogenicity of the mutation and predict age at disease onset

    Familial Alzheimer’s disease (FAD), caused by mutations in Presenilin (PSEN1/2) and Amyloid Precursor Protein (APP ) genes, is associated with an...

    Dieter Petit, Sara Gutiérrez Fernández, ... Lucía Chávez-Gutiérrez in Molecular Psychiatry
    Article Open access 01 April 2022
  20. Specifying Neuronal Cell Identities in the Central Nervous System: A Complex Tale of Proneural Gene Regulation

    The brain is characterized by an astounding diversity of neuronal phenotypes. In the last few decades, great strides have been made toward...
    Ana-Maria Oproescu, Yacine Touahri, ... Carol Schuurmans in Neuroscience in the 21st Century
    Reference work entry 2022
Did you find what you were looking for? Share feedback.